Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- M00378 - Provider product page
- Provider
- Boster Biological Technology
- Product name
- Anti-EGF Rabbit Monoclonal Antibody
- Antibody type
- Monoclonal
- Description
- Monoclonal antibody for EGF detection. Host: Rabbit.Size: 100ug/vial. Tested applications: IP, WB. Reactive species: Human EGF information: Molecular Weight: 133994 MW; Subcellular Localization: Membrane; Single-pass type I membrane protein; Tissue Specificity: Expressed in kidney, salivary gland, cerebrum and prostate.
- Reactivity
- Human
- Host
- Rabbit
- Antibody clone number
- ABOF-5
- Vial size
- 100ug/vial
- Concentration
- 0.5-1mg/ml, actual concentration vary by lot. Use suggested dilution ratio to decide dilution procedure.
- Storage
- At -20°C for one year. Avoid repeated freezing and thawing.
Submitted references Tissue-engineered edible bird's nests (TeeBN).
Association between epidermal growth factor 61A/G polymorphism and hepatocellular carcinoma susceptibility in Chinese patients.
Renal expression of epidermal growth factor and transforming growth factor-beta1 in children with congenital hydronephrosis.
Liu Y, Liu Y, Liu J, Li Y, Wan JB, Niu Y, Dong L, Du L, Wang C
International journal of bioprinting 2023;9(5):691
International journal of bioprinting 2023;9(5):691
Association between epidermal growth factor 61A/G polymorphism and hepatocellular carcinoma susceptibility in Chinese patients.
Li Y, Xie Q, Lu F, Zhao J, Mao P, Li Z, Liu S, Zhuang H
Liver international : official journal of the International Association for the Study of the Liver 2010 Jan;30(1):112-8
Liver international : official journal of the International Association for the Study of the Liver 2010 Jan;30(1):112-8
Renal expression of epidermal growth factor and transforming growth factor-beta1 in children with congenital hydronephrosis.
Yang Y, Hou Y, Wang CL, Ji SJ
Urology 2006 Apr;67(4):817-21; discussion 821-2
Urology 2006 Apr;67(4):817-21; discussion 821-2
No comments: Submit comment
No validations: Submit validation data